| Literature DB >> 27473864 |
Yalcin Velibey1, Ahmet Oz1, Ozan Tanik1, Tolga Sinan Guvenc1, Koray Kalenderoglu1, Ayca Gumusdag1, Evliya Akdeniz1, Mehmet Bozbay1, Ahmet Ilker Tekkesin1, Ozge Guzelburc1, Mert Ilker Hayiroglu1, Ahmet Taha Alper1, Murat Ugur1, Mehmet Eren1.
Abstract
We aimed to investigate the relationship between platelet-to-lymphocyte ratio (PLR) and contrast-induced acute kidney injury (CI-AKI) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). A total of 2563 patients diagnosed with STEMI and underwent primary pPCI were retrospectively included in the study. Levels of PLR and creatinine were measured before and at 72 hours after pPCI. Patients were divided into 2 groups: non-CI-AKI group and CI-AKI group. Contrast-induced acute kidney injury occurred in 6.4% of the overall study population. Patients in the CI-AKI group had significantly higher PLR than those in the non-CI-AKI group (169.18 ± 81.01 vs 149.49 ± 74.54, P < .001). In logistic regression analysis, PLR was an independent predictor of CI-AKI (odds ratio [OR]: 1.774, 95% CI: 1.243-2.532, P = .002), along with age, use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker prior to the procedure, preprocedural creatinine level, amount of contrast material used during the procedure, and hypertension. Increased PLR levels are independently associated with a greater risk of CI-AKI in patients undergoing primary PCI for STEMI.Entities:
Keywords: ST-segment elevation myocardial infarction; contrast-induced acute kidney injury; platelet-to-lymphocyte ratio; primary percutaneous coronary intervention
Mesh:
Substances:
Year: 2016 PMID: 27473864 DOI: 10.1177/0003319716660244
Source DB: PubMed Journal: Angiology ISSN: 0003-3197 Impact factor: 3.619